Dianthus Therapeutics, Inc. /DE/ Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Dianthus Therapeutics, Inc. /DE/ (DNTH) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $17.50 million as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2022-08-04
- 2022-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $17.50M.
- 2022-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $20.20M.
- 2021-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $21.80M.
- 2021-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $21.40M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2022-06-30 | $17.50M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $20.20M 10-Q · filed 2022-05-16 |
| 2021-09-30 | $21.80M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $21.40M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $20.30M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $18.70M 10-K · filed 2021-03-03 |
| 2020-09-30 | $20.80M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |